Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction

Journal of the American College of Cardiology

Volumn 41, Issue 4, 2003, Pages 539-545

  Koide, Shun Ichi ^a   Kugiyama, Kiyotaka ^a,b,c   Sugiyama, Seigo ^a   Nakamura, Shin Ichi ^a   Fukushima, Hironobu ^a   Honda, Osamu ^a   Yoshimura, Michihiro ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE;

AGE; AGED; ALLELE; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTICLE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DILATATION; CORONARY RISK; DISEASE ASSOCIATION; ENZYME ACTIVE SITE; GENE CONTROL; GENETIC POLYMORPHISM; GLUTATHIONE METABOLISM; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; UPREGULATION; VASOMOTOR DISORDER;

EID: 0037454012     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02866-8     Document Type: Article

References (27)

1. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990;344:160-2.
2. Griendling KK, Alexander RW. Endothelial control of the cardiovascular system: recent advances. FASEB J 1996;10:283-92.
3. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-906.
4. Kugiyama K, Yasue H, Ohgushi M, et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 1996;28:1161-7.
5. Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999;34:146-54.
6. Kugiyama K, Doi H, Motoyama T, et al. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation 1998;97:2519-26.
7. Doi H, Kugiyama K, Oka H, et al. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Circulation 2000;102:670-6.
8. Kinscherf R, Deigner HP, Usinger C, et al. Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J 1997;11:1317-28.
9. Makino Y, Okamoto K, Yoshikawa N, et al. Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action: cross talk between endocrine control of stress response and cellular antioxidant defense system. J Clin Invest 1996;98:2469-77.
10. 2 toxicity. Am J Physiol 1999;276:H167-75.
11. Cho S, Hazama M, Urata Y, et al. Protective role of glutathione synthesis in response to oxidized low-density lipoprotein in human vascular endothelial cells. Free Radic Biol Med 1999;26:589-602.
12. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983;52:711-60.
13. Murphy ME, Piper HM, Watanabe H, Sies H. Nitric oxide production by cultured aortic endothelial cells in response to thiol depletion and replenishment. J Biol Chem 1991;266:19378-83.
14. Kugiyama K, Ohgushi M, Motoyama T, et al. Intracoronary infusion of reduced glutathione improves endothelial vasomotor response to acetylcholine in human coronary circulation. Circulation 1998;97:2299-301.
15. Kugiyama K, Miyao Y, Sakamoto T, et al. Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina. Am J Physiol Heart Circ Physiol 2001;280:H264-71.
16. Prasad A, Andrews NP, Padder FA, Husain M, Quyyumi AA. Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailabillty. J Am Coll Cardlol 1999;34:507-14.
17. Rahman I, MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol 1999;277:L1067-88.
18. Mulcahy RT, Wartman MA, Bailey HH, Gipp JJ. Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J Biol Chem 1997;272:7445-54.
19. Galloway DC, Blake DG, Shepherd AG, McLellan LI. Regulation of human gamma-glutamylcysteine synthetase: coordinate induction of the catalytic and regulatory subunits in HepG2 cells. Biochem J 1997;328:99-104.
20. Keaney JF Jr, Vita JA. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Cardiovasc Dis 1995;38:129-54.
21. Yasue H, Matsuyama K, Okumura K, Morikami Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: possible role of early coronary atherosclerosis. Circulation 1990;81:482-90.
22. Sugiyama S, Kugiyama K, Ogata N, et al. Biphasic regulation of transcription factor nuclear factor-kappaB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arterioscler Thromb Vasc Biol 1998;18:568-76.
23. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
24. Morrison JA, Jacobsen DW, Sprecher DL, Robinson K, Khoury P, Daniels SR. Serum glutathione in adolescent males predicts parental coronary heart disease. Circulation 1999;100:2244-7.
25. Jain A, Martensson J, Mehta T, Krauss AN, Auld PA, Meister A. Ascorbic acid prevents oxidative stress in glutathione-deficient mice: effects on lung type 2 cell lamellar bodies, lung surfactant, and skeletal muscle. Proc Natl Acad Sci USA 1992;89:5093-7.
26. Beutler E, Gelbart T, Kondo T, Matsunaga AT. The molecular basis of a case of gamma-glutamylcysteine synthetase deficiency. Blood 1999;94:2890-4.
27. Ristoff E, Augustson C, Geissler J, et al. A missense mutation in the heavy subunit of gamma-glutamylcysteine synthetase gene causes hemolytic anemia. Blood 2000;95:2193-6.